<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8">
<meta name="Generator" content="Microsoft Word 15 (filtered medium)">
<!--[if !mso]><style>v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style><![endif]--><style><!--
/* Font Definitions */
@font-face
{font-family:"MS Gothic";
panose-1:2 11 6 9 7 2 5 8 2 4;}
@font-face
{font-family:"Cambria Math";
panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
{font-family:"Calibri Light";
panose-1:2 15 3 2 2 2 4 3 2 4;}
@font-face
{font-family:"\@MS Gothic";
panose-1:2 11 6 9 7 2 5 8 2 4;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0in;
font-size:11.0pt;
font-family:"Calibri",sans-serif;}
a:link, span.MsoHyperlink
{mso-style-priority:99;
color:blue;
text-decoration:underline;}
.MsoChpDefault
{mso-style-type:export-only;
font-size:10.0pt;}
@page WordSection1
{size:8.5in 11.0in;
margin:1.0in 1.0in 1.0in 1.0in;}
div.WordSection1
{page:WordSection1;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]-->
</head>
<body lang="EN-US" link="blue" vlink="purple" style="word-wrap:break-word">
<div class="WordSection1">
<p class="MsoNormal" style="margin-bottom:12.0pt"><o:p> </o:p></p>
<div>
<div>
<div>
<p class="MsoNormal" align="center" style="text-align:center"><span style="font-size:8.0pt;color:#404040;letter-spacing:.3pt">.</span><img width="288" height="79" style="width:3.0in;height:.8229in" id="Picture_x0020_3" src="cid:image001.png@01D90413.63B7F430" alt="A picture containing text, clipart
Description automatically generated"><o:p></o:p></p>
</div>
</div>
<div>
<p class="MsoNormal"><span style="font-size:13.0pt">November 29, 2022 </span><o:p></o:p></p>
</div>
<div>
<p class="MsoNormal"><span style="font-size:13.0pt"> </span><o:p></o:p></p>
</div>
<div>
<p class="MsoNormal"><span style="font-size:13.0pt">TO: NASTAD Members, Drug User Health, Syringe Services Programs (SSP), and Community-based Harm Reduction Partners </span><o:p></o:p></p>
</div>
<div>
<p class="MsoNormal"><span style="font-size:13.0pt">FR: Stephen Lee, Laura Pegram, Sharday Lewis, Alison Gaye, and Meredith McCarthy</span><o:p></o:p></p>
</div>
<div>
<p class="MsoNormal"><span style="font-size:13.0pt">RE: Funding Announcement: Strengthening Syringe Services Programs (SSP) through Direct Program Funding Request for Proposals (RFP) and Launch Webinar
</span><o:p></o:p></p>
</div>
<div>
<p class="MsoNormal"><span style="font-size:13.0pt;color:#201F1E"> </span><o:p></o:p></p>
</div>
<div>
<p class="MsoNormal"><span style="font-size:13.0pt">NASTAD and project partners, VOCAL-NY and University of Washington (UW), are excited to announce a CDC-supported funding opportunity:<b><i> Strengthening Syringe Services Programs (SSP) through Direct Program
Funding</i></b>. Please join us for a webinar on <b>Thursday, December 8, 3:30 – 5:00 PM ET</b> for an overview of the project and application technical assistance.
<a href="https://gcc02.safelinks.protection.outlook.com/?url=https%3A%2F%2Fnastad.zoom.us%2Fmeeting%2Fregister%2FtZYsc-iuqT4tGdY5Dry9ne5e1JoY2-PDEggP&data=05%7C01%7Cannick.benson%40dhsoha.state.or.us%7C4d0d95376afa459de9bd08dad24e6e13%7C658e63e88d39499c8f4813adc9452f4c%7C0%7C0%7C638053531573216058%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=287mQMEcUARpLbnhD0db6IQPjGpolzvXAB%2BY0dl2Yg8%3D&reserved=0">
<span style="color:#0563C1">Register for the webinar here. </span></a></span><o:p></o:p></p>
</div>
<div>
<p class="MsoNormal"><span style="font-size:13.0pt"> </span><o:p></o:p></p>
</div>
<div>
<p class="MsoNormal"><span style="font-size:13.0pt">In 2022, collaborative Centers within the Centers for Disease Control and Prevention (CDC), developed the
<b><i>Strengthening Syringe Services Programs – Component 2: Funding</i></b><i> </i>
opportunity (CDC-RFA-PS22-2208) which was awarded to NASTAD and partners VOCAL-NY and the University of Washington (UW).<b>
</b>This five-year project aims to strengthen the capacity of SSPs through direct program funding, provided through NASTAD, to continue serving as critically essential access points for core syringe and safer drug use supplies, overdose prevention information
and materials, and a range of services for PWUDs such as adult vaccination services, HIV and viral hepatitis testing and linkage to care services, and referral and navigation efforts.
</span><o:p></o:p></p>
</div>
<div>
<p class="MsoNormal"><span style="font-size:13.0pt"> </span><o:p></o:p></p>
</div>
<div>
<p class="MsoNormal"><b><span style="font-size:13.0pt">NASTAD and project partners are charged with soliciting, selecting, issuing, and monitoring subawards within a range of $50,000-$150,000 each to forty (40) to eighty (80) sites dependent on award amount
in year 1 of this five-year cooperative agreement. These resources will be used to support current SSP efforts within selected sites, bolster expansion and reach of SSP services, and can be used for staffing/benefits, infrastructure, and SSP supplies (in alignment
with current federal allowability). </span></b><o:p></o:p></p>
</div>
<div>
<p class="MsoNormal"><span style="font-size:13.0pt"> </span><o:p></o:p></p>
</div>
<div>
<p class="MsoNormal"><b><span style="font-size:13.0pt">The funding awarded in year 1 will be the first year of
</span></b><a name="_Int_y62N74az"></a><span style="font-size:13.0pt">the anticipated two (2)-year subawards for each selected site. Additional funds and funding opportunities will be made available in each subsequent year of this five-year funding project
for both the year 1-funded sites as well as additional programs, dependent on resource allocation and availability.</span><o:p></o:p></p>
</div>
<div>
<p class="MsoNormal"><span style="font-size:13.0pt"> </span><o:p></o:p></p>
</div>
<div>
<p class="MsoNormal"><span style="font-size:13.0pt"><a href="https://gcc02.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.grantinterface.com%2FHome%2FLogon%3Furlkey%3Dnastad&data=05%7C01%7Cannick.benson%40dhsoha.state.or.us%7C4d0d95376afa459de9bd08dad24e6e13%7C658e63e88d39499c8f4813adc9452f4c%7C0%7C0%7C638053531573216058%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=xSKB%2FBkNo0BjsN7Cu5R2Af7Rt70KIkSwHDNutsm1db8%3D&reserved=0"><b><span style="color:#0563C1">The
RFP application is now live and can be found here.</span></b></a><b> </b></span><o:p></o:p></p>
</div>
<div>
<p class="MsoNormal"><span style="font-size:13.0pt"> </span><o:p></o:p></p>
</div>
<div style="margin-top:5.0pt;margin-bottom:5.0pt">
<p class="MsoNormal"><span style="font-size:13.0pt">A project overview, general Q&A page, and
<a href="https://gcc02.safelinks.protection.outlook.com/?url=https%3A%2F%2Fnastad.org%2Fcareers%2Fstrengthening-syringe-services-programs-ssps-through-direct-program-funding-request&data=05%7C01%7Cannick.benson%40dhsoha.state.or.us%7C4d0d95376afa459de9bd08dad24e6e13%7C658e63e88d39499c8f4813adc9452f4c%7C0%7C0%7C638053531573216058%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=M25GUbrrshp5NrhiHUgkWo7%2BBxi4Pql1qNnc%2FoeP0Mo%3D&reserved=0">
resources to support the application process can be found here</a>. </span><o:p></o:p></p>
<p class="MsoNormal"><span style="font-size:13.0pt"> </span><o:p></o:p></p>
<p class="MsoNormal" style="margin-bottom:5.0pt"><span style="font-size:13.0pt">The December 8 webinar will include a discussion the rationale and intention behind this funding opportunity, a walkthrough of the application elements, project timeline, eligibility
criteria, and time for Q&A. Please contact our drug user health team members working on this exciting and innovative project via
<a href="mailto:druguserhealthta@nastad.org"><span style="color:#0563C1">druguserhealthta@nastad.org</span></a> for further information.
</span><o:p></o:p></p>
</div>
<p class="MsoNormal"><span style="font-size:13.0pt"> </span><o:p></o:p></p>
<p class="MsoNormal"><b><span style="font-size:14.0pt;font-family:"Calibri Light",sans-serif;color:#008FC5;letter-spacing:.3pt">Stephen Lee MD, MBA, DHSM</span></b><o:p></o:p></p>
<p class="MsoNormal"><span style="color:#313131">Executive Director</span><o:p></o:p></p>
<p class="MsoNormal"><span style="color:#313131">Pronouns: He/Him/His</span><span style="font-family:"MS Gothic";color:black">
</span><o:p></o:p></p>
<p class="MsoNormal"><span style="color:#313131">202.897.0028 | <a href="mailto:slee@NASTAD.org"><span style="color:#0B4CB4">slee@NASTAD.org</span></a></span><o:p></o:p></p>
<p class="MsoNormal"><span style="color:#313131">Connect with us: </span><span style="color:black"> <a href="https://gcc02.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fnastad&data=05%7C01%7Cannick.benson%40dhsoha.state.or.us%7C4d0d95376afa459de9bd08dad24e6e13%7C658e63e88d39499c8f4813adc9452f4c%7C0%7C0%7C638053531573216058%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=jhGh4Vt4rx3geaPxoY3oth77fUsrZZkfnf83QYusniU%3D&reserved=0"><span style="color:#0B4CB4">LinkedIn</span></a></span><u><span style="color:#0B4CB4"> </span></u><span style="color:black">| <a href="https://gcc02.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.facebook.com%2FNASTAD&data=05%7C01%7Cannick.benson%40dhsoha.state.or.us%7C4d0d95376afa459de9bd08dad24e6e13%7C658e63e88d39499c8f4813adc9452f4c%7C0%7C0%7C638053531573216058%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=7%2F59oTsQysnFAmYKEzPiOEhbinEb7EsSXYDj5Mxn5cE%3D&reserved=0"><span style="color:#0B4CB4">Facebook</span></a></span><u><span style="color:#0B4CB4"> </span></u><span style="color:black">| <a href="https://gcc02.safelinks.protection.outlook.com/?url=https%3A%2F%2Ftwitter.com%2FNASTAD&data=05%7C01%7Cannick.benson%40dhsoha.state.or.us%7C4d0d95376afa459de9bd08dad24e6e13%7C658e63e88d39499c8f4813adc9452f4c%7C0%7C0%7C638053531573216058%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=swJciLg%2FMkjMlBo6%2Bx79enJWQ3KJ5CjXm4oa658ZXbk%3D&reserved=0"><span style="color:#0B4CB4">Twitter</span></a></span><u><span style="color:#0B4CB4"> </span></u><span style="color:black">| <a href="https://gcc02.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.youtube.com%2Fuser%2FNASTAD1992&data=05%7C01%7Cannick.benson%40dhsoha.state.or.us%7C4d0d95376afa459de9bd08dad24e6e13%7C658e63e88d39499c8f4813adc9452f4c%7C0%7C0%7C638053531573216058%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=aPw%2BdAlQ8UfPG8VVZLvlrzQxB1k4NqRMSst%2FOkX5UMI%3D&reserved=0"><span style="color:#0B4CB4">YouTube</span></a> |</span><u><span style="color:#0B4CB4"> <a href="https://gcc02.safelinks.protection.outlook.com/?url=http%3A%2F%2Fwww.instagram.com%2Fnastad1992&data=05%7C01%7Cannick.benson%40dhsoha.state.or.us%7C4d0d95376afa459de9bd08dad24e6e13%7C658e63e88d39499c8f4813adc9452f4c%7C0%7C0%7C638053531573372283%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=qM4pbEuCeZdgeHkza4uofg2kqISb4WLt3jskQSYWKBE%3D&reserved=0"><span style="color:#0B4CB4">Instagram</span></a></span></u><span style="font-family:"MS Gothic";color:#18376A">
</span><o:p></o:p></p>
<p class="MsoNormal"><b><span style="color:#0C7BB8">NASTAD</span></b><span style="color:#0F7BB8"> </span><span style="color:#313131">| <a href="webextlink://444%20North%20Capitol%20Street%20NW,%20Suite%20339%20|%20Washington,%20DC%2020001" title="webextlink://444 North Capitol Street NW, Suite 339 | Washington, DC 20001"><span style="color:#0072C6">444
North Capitol Street NW, Suite 339 | Washington, DC 20001</span></a>| <a href="https://gcc02.safelinks.protection.outlook.com/?url=http%3A%2F%2Fwww.nastad.org%2F&data=05%7C01%7Cannick.benson%40dhsoha.state.or.us%7C4d0d95376afa459de9bd08dad24e6e13%7C658e63e88d39499c8f4813adc9452f4c%7C0%7C0%7C638053531573372283%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=TpQu4X%2FqKh6i3r7B65%2BWZxz8r1Ly2Fvd3P2VSYilM%2BY%3D&reserved=0"><span style="color:#313131">NASTAD.org</span></a></span><o:p></o:p></p>
<p class="MsoNormal"><span style="font-size:8.0pt;color:#313131">This email and any files transmitted with it are confidential and intended solely for the use of the entity to whom they are addressed. If you received this email in error please notify the sender.</span><o:p></o:p></p>
</div>
</div>
</body>
</html>